Distinct role of IL-1β in instigating disease in Sharpin cpdm mice

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Gurung, Prajwal ^a   Sharma, Bhesh Raj ^a   Kanneganti, Thirumala Devi ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; IL1B PROTEIN, MOUSE; INTERLEUKIN 1BETA; SIPL1 PROTEIN, MOUSE;

ANIMAL; DERMATITIS; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; MOUSE; PATHOLOGY; SIGNAL TRANSDUCTION; SKIN; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ANIMALS; CARRIER PROTEINS; DERMATITIS; INTERLEUKIN-1BETA; MICE; MICE, KNOCKOUT; SIGNAL TRANSDUCTION; SKIN; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 84999634768     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep36634     Document Type: Article

References (37)

1. HogenEsch, H. et al. A spontaneous mutation characterized by chronic proliferative dermatitis in C57BL mice. Am J Pathol 143, 972-982 (1993
2. Seymour, R. E. et al. Spontaneous mutations in the mouse Sharpin gene result in multiorgan inflammation, immune system dysregulation and dermatitis. Genes Immun 8, 416-421 (2007
3. Gurung, P., & Kanneganti, T. D. Autoinflammatory Skin Disorders: The Inflammasomme in Focus. Trends Mol Med (2016
4. Gerlach, B. et al. Linear ubiquitination prevents inflammation and regulates immune signalling. Nature 471, 591-596 (2011
5. Ikeda, F. et al. SHARPIN forms a linear ubiquitin ligase complex regulating NF-kappaB activity and apoptosis. Nature 471, 637-641 (2011
6. Tokunaga, F. et al. SHARPIN is a component of the NF-kappaB-Activating linear ubiquitin chain assembly complex. Nature 471, 633-636 (2011
7. Kumari, S. et al. Sharpin prevents skin inflammation by inhibiting TNFR1-induced keratinocyte apoptosis. Elife 3 (2014
8. Rickard, J. A. et al. TNFR1-dependent cell death drives inflammation in Sharpin-deficient mice. Elife 3 (2014
9. Douglas, T., Champagne, C., Morizot, A., Lapointe, J. M., & Saleh, M. The Inflammatory Caspases-1 and -11 Mediate the Pathogenesis of Dermatitis in Sharpin-Deficient Mice. J Immunol 195, 2365-2373 (2015
10. Dinarello, C. A. IL-1: discoveries, controversies and future directions. Eur J Immunol 40, 599-606 (2010
11. Garlanda, C., Dinarello, C. A., & Mantovani, A. The interleukin-1 family: back to the future. Immunity 39, 1003-1018 (2013
12. Kanneganti, T. D. The inflammasome: firing up innate immunity. Immunol Rev 265, 1-5 (2015
13. Lamkanfi, M., & Kanneganti, T. D. Nlrp3: an immune sensor of cellular stress and infection. Int J Biochem Cell Biol 42, 792-795 (2010
14. Man, S. M., & Kanneganti, T. D. Regulation of inflammasome activation. Immunol Rev 265, 6-21 (2015
15. McDermott, D. S., & Varga, S. M. Quantifying antigen-specific CD4 T cells during a viral infection: CD4 T cell responses are larger than we think. J Immunol 187, 5568-5576 (2011
16. Rai, D., Pham, N. L., Harty, J. T., & Badovinac, V. P. Tracking the total CD8 T cell response to infection reveals substantial discordance in magnitude and kinetics between inbred and outbred hosts. J Immunol 183, 7672-7681 (2009
17. Berger, S. B. et al. Cutting Edge: RIP1 kinase activity is dispensable for normal development but is a key regulator of inflammation in SHARPIN-deficient mice. J Immunol 192, 5476-5480 (2014
18. HogenEsch, H., Janke, S., Boggess, D., & Sundberg, J. P. Absence of Peyer's patches and abnormal lymphoid architecture in chronic proliferative dermatitis (cpdm/cpdm) mice. J Immunol 162, 3890-3896 (1999
19. Redecke, V., Chaturvedi, V., Kuriakose, J., & Hacker, H. SHARPIN controls the development of regulatory T cells. Immunology 148, 216-226 (2016
20. Park, Y. et al. SHARPIN controls regulatory T cells by negatively modulating the T cell antigen receptor complex. Nat Immunol 17, 286-296 (2016
21. Potter, C. S. et al. Chronic proliferative dermatitis in Sharpin null mice: development of an autoinflammatory disease in the absence of B and T lymphocytes and IL4/IL13 signaling. PLoS One 9, e85666 (2014
22. Gijbels, M. J., HogenEsch, H., Bruijnzeel, P. L., Elliott, G. R., & Zurcher, C. Maintenance of donor phenotype after full-thickness skin transplantation from mice with chronic proliferative dermatitis (cpdm/cpdm) to C57BL/Ka and nude mice and vice versa. J Invest Dermatol 105, 769-773 (1995
23. Gurung, P., Lamkanfi, M., & Kanneganti, T. D. Cutting edge: SHARPIN is required for optimal NLRP3 inflammasome activation. J Immunol 194, 2064-2067 (2015
24. Rodgers, M. A. et al. The linear ubiquitin assembly complex (LUBAC) is essential for NLRP3 inflammasome activation. J Exp Med 211, 1333-1347 (2014
25. Gurung, P., Lukens, J. R., & Kanneganti, T. D. Mitochondria: diversity in the regulation of the NLRP3 inflammasome. Trends Mol Med 21, 193-201 (2015
26. Cavalli, G., & Dinarello, C. A. Treating rheumatological diseases and co-morbidities with interleukin-1 blocking therapies. Rheumatology (Oxford) 54, 2134-2144 (2015
27. Lukens, J. R. et al. Critical role for inflammasome-independent IL-1beta production in osteomyelitis. Proc Natl Acad Sci USA 111, 1066-1071 (2014
28. Gurung, P., Burton, A., & Kanneganti, T. D. NLRP3 inflammasome plays a redundant role with caspase 8 to promote IL-1betamediated osteomyelitis. Proc Natl Acad Sci USA 113, 4452-4457 (2016
29. Lukens, J. R. et al. Dietary modulation of the microbiome affects autoinflammatory disease. Nature 516, 246-249 (2014
30. Lukens, J. R. et al. RIP1-driven autoinflammation targets IL-1alpha independently of and RIP3. Nature 498, 224-227 (2013
31. Lukens, J. R., & Kanneganti, T. D. SHP-1 and IL-1alpha conspire to provoke neutrophilic dermatoses. Rare Dis 2, e27742 (2014
32. Kayagaki, N. et al. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature 526, 666-671 (2015
33. Shi, J. et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature 526, 660-665 (2015
34. Matsuki, T., Nakae, S., Sudo, K., Horai, R., & Iwakura, Y. Abnormal T cell activation caused by the imbalance of the IL-1/IL-1R antagonist system is responsible for the development of experimental autoimmune encephalomyelitis. Int Immunol 18, 399-407 (2006
35. Shornick, L. P. et al. Mice deficient in IL-1beta manifest impaired contact hypersensitivity to trinitrochlorobenzone. J Exp Med 183, 1427-1436 (1996
36. Glaccum, M. B. et al. Phenotypic and functional characterization of mice that lack the type I receptor for IL-1. J Immunol 159, 3364-3371 (1997
37. Gurung, P. et al. An NLRP3 inflammasome-triggered Th2-biased adaptive immune response promotes leishmaniasis. J Clin Invest 125, 1329-1338 (2015